YM BIOSCIENCES INC (CIK: 0001178347) EDGAR, Information, Filings... CompaniesBIO.Com

YM BIOSCIENCES INC

Mailing address
Phone
N/A
State location
A6
State of incorporation
N/A
Fiscal year end
N/A
SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
Filings
N/A

YM BIOSCIENCES INC (CIK: 0001178347) is an American company incorporated in the state of A6. Head office is located at 5045 ORBITOR DRIVE, BUILDING 11 SUITE 400, MISSISSAUGA, A6, 00000. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. YM BIOSCIENCES INC is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
XMARK ASSET MANAGEMENT LLC	0001118481	Dec-12-2005	other: Disclaimed Group
Xmark Opportunity Partners, LLC	0001347039	Dec-12-2005	other: Disclaimed Group

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by YM BIOSCIENCES INC

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000919574-14-001581 (34 Act) Size: KB	Feb-14-2014	005-80086 14613456
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001085146-14-000437 (34 Act) Size: KB	Feb-11-2014	005-80086 14591041
15-12B	Document	Notice of termination of registration of a class of securities under Section 12(b) Acc-no: 0001193125-13-071199 (34 Act) Size: KB	Feb-22-2013	001-32186 13633692
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-13-069216 (34 Act) Size: KB	Feb-21-2013	001-32186 13630254
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-13-062759 (33 Act) Size: KB	Feb-15-2013	333-134410 13619973
F-10POS	Document	Post-effective amendment to a F-10EF registration Acc-no: 0001193125-13-062745 (33 Act) Size: KB	Feb-15-2013	333-175381 13619945
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000315066-13-002931 (34 Act) Size: KB	Feb-14-2013	005-80086 13611741
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000919574-13-001626 (34 Act) Size: KB	Feb-14-2013	005-80086 13609829
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001144204-13-008658 (34 Act) Size: KB	Feb-14-2013	005-80086 13607734
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001085146-13-000544 (34 Act) Size: KB	Feb-14-2013	005-80086 13607189
25-NSE/A	Document	Acc-no: 0001143313-13-000009 (34 Act) Size: KB	Feb-12-2013	001-32186
25-NSE	Document	Acc-no: 0001143313-13-000007 (34 Act) Size: KB	Feb-12-2013	001-32186
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001279569-13-000152 (34 Act) Size: KB	Feb-08-2013	001-32186 13587929
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001279569-13-000149 (34 Act) Size: KB	Feb-07-2013	001-32186 13581370
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001279569-13-000147 (34 Act) Size: KB	Feb-07-2013	001-32186 13581350
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001279569-13-000130 (34 Act) Size: KB	Feb-05-2013	001-32186 13573100
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001144204-13-005883 (34 Act) Size: KB	Feb-05-2013	005-80086 13571260
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001279569-13-000103 (34 Act) Size: KB	Jan-31-2013	001-32186 13561699
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001279569-13-000067 (34 Act) Size: KB	Jan-18-2013	001-32186 13536467
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001104659-13-001815 (34 Act) Size: KB	Jan-10-2013	001-32186 13522850

Recent 20 filings. View all YM BIOSCIENCES INC filings

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Where is YM BIOSCIENCES INC's headquarters?

YM BIOSCIENCES INC is located in 5045 ORBITOR DRIVE, BUILDING 11 SUITE 400, MISSISSAUGA, A6, 00000.

What is the YM BIOSCIENCES INC's website?

YM BIOSCIENCES INC's website is unknown

Who invested in YM BIOSCIENCES INC?

Updating!

How much funding has YM BIOSCIENCES INC raised to date?

Updating!

When was the last funding round for YM BIOSCIENCES INC?

Updating!

When was YM BIOSCIENCES INC founded?

Updating!

YM BIOSCIENCES INC overview
YM BIOSCIENCES INC job
YM BIOSCIENCES INC stock
YM BIOSCIENCES INC ownership
YM BIOSCIENCES INC CEO
YM BIOSCIENCES INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.